![@Drunemeton@lemmy.world cover](https://kbin.chat/media/cache/resolve/user_cover/40/e6/40e612c0a620a97b198d653c2dff1fe3a5672eb0670e18fd24b25e2e9949a729.jpg)
Just your average urban druid interested in technology and quantum field theory.
This profile is from a federated server and may be incomplete. View on remote instance
Just your average urban druid interested in technology and quantum field theory.
This profile is from a federated server and may be incomplete. View on remote instance
What's your biggest gamer achievement?
If your mind got transported back 10 years right now with no time to prepare, how could you exploit your knowledge for personal gain?
Besides crypto...
‘Make Europe Great Again’: Hungary’s new motto for EU presidency has a familiar ring to it ( www.wral.com )
🤦
New Type Ia supernova discovered ( phys.org )
Supermassive black hole roars to life as astronomers watch in real time ( arstechnica.com )
In December 2019, astronomers were surprised to observe a long-quiet galaxy, 300 million light-years away, suddenly come alive, emitting ultraviolet, optical, and infrared light into space. Far from quieting down again, by February of this year, the galaxy had begun emitting X-ray light; it is becoming more active. Astronomers...
Voyager 1 is fully back online months after it stopped making sense. ( www.theverge.com )
I still can't believe how this one comes back again and again. One of the greatest feat of humanity.
Elon Musk threatens to ban Apple devices from his companies over OpenAI partnership ( www.cnbc.com )
Is there a "canvas" of the universe? Do we even know? Would a canvas follow the same laws as the paint?
Think of the universe as a painting. There's the image made in paint, and the surface it was painted on. The canvas....
BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study ( www.bluerocktx.com )
BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study::Investigational Bemdaneprocel (BRT-DA01) was well tolerated with no major safety issues in all 12 patients through one year Assessment of secondary endpoints demonstrates feasibility of transplantation...